Harold I. Feldman, MD, MSCE, of the Perelman School of Medicine (PSOM) at the University of Pennsylvania has been named the next Editor-in-Chief of the National Kidney Foundation’s American Journal of Kidney Diseases (AJKD). His five-year term begins January 1, 2017.
“I am honored to have the opportunity to lead this journal, which carries a legacy of so many talented editors. I look forward to bringing the best clinical science to the renal community, with the help of an editorial team of highly accomplished professionals and clinical scientists,” Dr. Feldman said.
Founded as NKF’s official journal in 1981, AJKD is recognized worldwide as a leading source of information on clinical nephrology practice and clinical research. Its current Editor-in-Chief, Dr. Andrew Levey, of Tufts University Medical Center, is in his tenth year in the position, having served two consecutive terms. Under Dr. Levey’s leadership, the journal instituted universal statistical review of research articles and extended the range of original investigations to encompass quality improvement reports, qualitative research, and prediction models. Since 2007, AJKD more than doubled its online usage and experienced a 33% boost in Impact Factor and a 34% increase in submissions.
As Editor-in-Chief, Dr. Feldman aims to make AJKD more international by bringing in editors from outside North America. “I see good potential for us to expand our readership and further develop our coverage of some research disciplines that have received less attention over the years,” Dr. Feldman said. He plans to expand the journal’s content with such topics as patient-centered outcomes research, health policy, pediatric nephrology, and transplantation, and has enlisted co-editors who have expertise in these areas. He will be ably supported by Deputy Editors Jeffrey Berns, MD, President of the National Kidney Foundation, and Laura Dember, MD, both at University of Pennsylvania.
“I am very excited to be part of the new AJKD Editorial Team,” said Dr. Berns. The current team led by Dr. Levey and Dan Weiner has been phenomenal, and I look forward to continuing their great work and finding new opportunities to keep AJKD as an important and impactful journal for nephrologists in all parts of the world.”
Dr. Feldman plays several leading roles in the PSOM at the University of Pennsylvania. He is the George S. Pepper Professor of Public Health and Preventive Medicine, Chair of the Department of Biostatistics and Epidemiology, and Director of the Center for Clinical Epidemiology and Biostatistics. He is a board-certified nephrologist with an appointment in the Renal Electrolyte and Hypertension Division of PSOM’s Department of Medicine. He also leads numerous major national research efforts, including the National Institutes of Health’s Chronic Renal Insufficiency Cohort Study (CRIC). Under the auspices of the National Institute of Diabetes and Digestive and Kidney Disease, Dr. Feldman directs the Hemodialysis Fistula Maturation Cohort Study and the Coordinating Center of the Chronic Kidney Disease Biomarkers Consortium.
The National Kidney Foundation is the leading organization in the U.S. dedicated to the awareness, prevention and treatment of kidney disease. For more information, visit www.kidney.org.